These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31378897)

  • 1. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
    Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
    Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
    Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
    Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA SNHG1 suppresses gastric cancer cell proliferation and promotes apoptosis via Notch1 pathway.
    Zhang Z; Wang H
    J BUON; 2020; 25(1):302-307. PubMed ID: 32277646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of long noncoding RNA SNHG1 inhibits cell proliferation, metastasis, and invasion by suppressing the Notch-1 signaling pathway in pancreatic cancer.
    Cui L; Dong Y; Wang X; Zhao X; Kong C; Liu Y; Jiang X; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6106-6112. PubMed ID: 30520072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
    Li SJ; Wang L; Sun ZX; Sun SJ; Gao J; Ma RL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2768-2776. PubMed ID: 31002127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
    Li Y; Xu J; Guo YN; Yang BB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis.
    Liu ZQ; He WF; Wu YJ; Zhao SL; Wang L; Ouyang YY; Tang SY
    BMC Gastroenterol; 2020 May; 20(1):156. PubMed ID: 32423385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
    Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
    Cui P; Dai X; Liu R; Cao H
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22878. PubMed ID: 34472153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma.
    Wang Q; Li Q; Zhou P; Deng D; Xue L; Shao N; Peng Y; Zhi F
    Biomed Pharmacother; 2017 Jul; 91():906-911. PubMed ID: 28501778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis
    Piao HY; Guo S; Wang Y; Zhang J
    World J Gastroenterol; 2019 Nov; 25(44):6508-6526. PubMed ID: 31802831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
    Zhang M; Yang L; Hou L; Tang X
    Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 overexpression regulates the proliferation of acute myeloid leukemia cells through miR-488-5p/NUP205 axis.
    Bao XL; Zhang L; Song WP
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5896-5903. PubMed ID: 31298340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression.
    Wang LJ; Sun GZ; Chen YF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3375-3382. PubMed ID: 31081092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
    Guo Q; Qian Z; Yan D; Li L; Huang L
    Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.